Showing results 1 to 6 of 6
Title | Author(s) | Issue Date | |
---|---|---|---|
A Novel Splice Variant to NCOR2 as Biomarker for Tamoxifen Resistant Breast Cancer Proceeding/Conference:WIN 2017 Symposium | 2017 | ||
BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer Journal:Clinical Cancer Research | 2018 | ||
In vivo genome-wide CRISPR activation screening identifies functionally important long non-coding RNAs in hepatocellular carcinoma. Journal:Cell Mol Gastroenterol Hepatol | 2022 | ||
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 |